BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 26812442)

  • 1. EEG Brain Wave Activity at Rest and during Evoked Attention in Children with Attention-Deficit/Hyperactivity Disorder and Effects of Methylphenidate.
    Thomas BL; Viljoen M
    Neuropsychobiology; 2016; 73(1):16-22. PubMed ID: 26812442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate.
    Negrao BL; Bipath P; van der Westhuizen D; Viljoen M
    Neuropsychobiology; 2011; 63(2):82-91. PubMed ID: 21178382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of methylphenidate on the power spectrum of ADHD children - an MEG study.
    Wienbruch C; Paul I; Bauer S; Kivelitz H
    BMC Psychiatry; 2005 Jul; 5():29. PubMed ID: 16042816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of stimulant medications on children with attention-deficit/hyperactivity disorder and excessive beta activity in their EEG.
    Clarke AR; Barry RJ; McCarthy R; Selikowitz M; Clarke DC; Croft RJ
    Clin Neurophysiol; 2003 Sep; 114(9):1729-37. PubMed ID: 12948803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of stimulant medications on the EEG of girls with Attention-Deficit/Hyperactivity Disorder.
    Clarke AR; Barry RJ; McCarthy R; Selikowitz M; Johnstone SJ
    Clin Neurophysiol; 2007 Dec; 118(12):2700-8. PubMed ID: 17911040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EEG differences between good and poor responders to methylphenidate in boys with the inattentive type of attention-deficit/hyperactivity disorder.
    Clarke AR; Barry RJ; McCarthy R; Selikowitz M; Croft RJ
    Clin Neurophysiol; 2002 Aug; 113(8):1191-8. PubMed ID: 12139997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [EEG diagnosis before beginning and during drug treatment of hyperkinetic children and adolescents].
    Gabriel KH
    Z Kinder Jugendpsychiatr Psychother; 2003 Aug; 31(3):231-2; author reply 233-4. PubMed ID: 12942795
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrophysiological effects of stimulant treatment on inhibitory control in children with attention-deficit/hyperactivity disorder.
    Pliszka SR; Liotti M; Bailey BY; Perez R; Glahn D; Semrud-Clikeman M
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):356-66. PubMed ID: 17630869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of d-Methylphenidate, Guanfacine, and Their Combination on Electroencephalogram Resting State Spectral Power in Attention-Deficit/Hyperactivity Disorder.
    Loo SK; Bilder RM; Cho AL; Sturm A; Cowen J; Walshaw P; Levitt J; Del'Homme M; Piacentini J; McGough JJ; McCracken JT
    J Am Acad Child Adolesc Psychiatry; 2016 Aug; 55(8):674-682.e1. PubMed ID: 27453081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral Effects of Neurofeedback Compared to Stimulants and Physical Activity in Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial.
    Geladé K; Janssen TW; Bink M; van Mourik R; Maras A; Oosterlaan J
    J Clin Psychiatry; 2016 Oct; 77(10):e1270-e1277. PubMed ID: 27631143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects.
    Williams LM; Hermens DF; Palmer D; Kohn M; Clarke S; Keage H; Clark CR; Gordon E
    Biol Psychiatry; 2008 May; 63(10):917-26. PubMed ID: 18272140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attentional capacity, a probe ERP study: differences between children with attention-deficit hyperactivity disorder and normal control children and effects of methylphenidate.
    Jonkman LM; Kemner C; Verbaten MN; Van Engeland H; Camfferman G; Buitelaar JK; Koelega HS
    Psychophysiology; 2000 May; 37(3):334-46. PubMed ID: 10860411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate, Guanfacine, and Combined Treatment Effects on Electroencephalography Correlates of Spatial Working Memory in Attention-Deficit/Hyperactivity Disorder.
    Michelini G; Lenartowicz A; Diaz-Fong JP; Bilder RM; McGough JJ; McCracken JT; Loo SK
    J Am Acad Child Adolesc Psychiatry; 2023 Jan; 62(1):37-47. PubMed ID: 35963558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Event-related wave activity in the EEG provides new marker of ADHD.
    Alexander DM; Hermens DF; Keage HA; Clark CR; Williams LM; Kohn MR; Clarke SD; Lamb C; Gordon E
    Clin Neurophysiol; 2008 Jan; 119(1):163-79. PubMed ID: 18054279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulant drug action in attention deficit hyperactivity disorder (ADHD): inference of neurophysiological mechanisms via quantitative modelling.
    Rowe DL; Robinson PA; Gordon E
    Clin Neurophysiol; 2005 Feb; 116(2):324-35. PubMed ID: 15661111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate dependency revisited: understanding the effects of methylphenidate in children with attention deficit hyperactivity disorder.
    Teicher MH; Polcari A; Anderson CM; Andersen SL; Lowen SB; Navalta CP
    J Child Adolesc Psychopharmacol; 2003; 13(1):41-51. PubMed ID: 12804125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptual and response interference in children with attention-deficit hyperactivity disorder, and the effects of methylphenidate.
    Jonkman LM; Kemner C; Verbaten MN; Van Engeland H; Kenemans JL; Camfferman G; Buitelaar JK; Koelega HS
    Psychophysiology; 1999 Jul; 36(4):419-29. PubMed ID: 10432791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder.
    Schweren LJ; de Zeeuw P; Durston S
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1151-64. PubMed ID: 23165220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Waived EEG diagnosis before administration and during drug therapy with methylphenidate: dangerous or justifiable?].
    Schmidt JK; Plück J; von Gontard A
    Z Kinder Jugendpsychiatr Psychother; 2002 Nov; 30(4):295-302. PubMed ID: 12474320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.